Tarsus Pharmaceuticals, Inc. (TARS)
USD 46.86
(-5.43%)
USD 46.86
(-5.43%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -193.21 Million USD | -275.14% |
| 2022 | -51.5 Million USD | 69.6% |
| 2021 | -169.44 Million USD | -1.28% |
| 2020 | -167.29 Million USD | -189.5% |
| 2019 | -57.78 Million USD | -2353.84% |
| 2018 | -2.35 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -163.18 Million USD | 15.54% |
| 2024 Q2 | -108.91 Million USD | 33.26% |
| 2023 Q4 | -193.21 Million USD | 1.69% |
| 2023 Q2 | -81.73 Million USD | -97.04% |
| 2023 Q3 | -196.54 Million USD | -140.46% |
| 2023 Q1 | -41.48 Million USD | 19.46% |
| 2023 FY | -193.21 Million USD | -275.14% |
| 2022 Q1 | -154.59 Million USD | 8.76% |
| 2022 FY | -51.5 Million USD | 69.6% |
| 2022 Q4 | -51.5 Million USD | 65.52% |
| 2022 Q3 | -149.39 Million USD | 33.66% |
| 2022 Q2 | -225.19 Million USD | -45.67% |
| 2021 Q2 | -174.59 Million USD | -12.28% |
| 2021 Q3 | -181.47 Million USD | -3.94% |
| 2021 Q1 | -155.5 Million USD | 7.05% |
| 2021 Q4 | -169.44 Million USD | 6.63% |
| 2021 FY | -169.44 Million USD | -1.28% |
| 2020 FY | -167.29 Million USD | -189.5% |
| 2020 Q2 | -52.28 Million USD | 0.0% |
| 2020 Q4 | -167.29 Million USD | -95.64% |
| 2020 Q3 | -85.51 Million USD | -63.57% |
| 2019 Q4 | -57.78 Million USD | 0.0% |
| 2019 FY | -57.78 Million USD | -2353.84% |
| 2018 FY | -2.35 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -245.397% |
| Alkermes plc | -166.73 Million USD | -15.879% |
| Agenus Inc. | 274.13 Million USD | 170.481% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 110.333% |
| Aptorum Group Limited | 1.35 Million USD | 14337.911% |
| Ardelyx, Inc. | 34.51 Million USD | 659.849% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4614.369% |
| Bicycle Therapeutics plc | -481.46 Million USD | 59.87% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 634.289% |
| ChromaDex Corporation | -24.04 Million USD | -703.456% |
| Chimerix, Inc. | -25.51 Million USD | -657.201% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2872.86% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -716.045% |
| CRISPR Therapeutics AG | -150.84 Million USD | -28.088% |
| Precision BioSciences, Inc. | -85.41 Million USD | -126.221% |
| Dyadic International, Inc. | -6.37 Million USD | -2929.351% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1112.672% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2620.744% |
| Lantern Pharma Inc. | -21.7 Million USD | -790.257% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -74.797% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2161.63% |
| Incyte Corporation | -3.17 Billion USD | 93.915% |
| IO Biotech, Inc. | -140.69 Million USD | -37.325% |
| Jaguar Health, Inc. | 29.39 Million USD | 757.395% |
| Novavax, Inc. | -298.29 Million USD | 35.227% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3720.292% |
| Opthea Limited | 28.15 Million USD | 786.195% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1050.843% |
| ContextLogic Inc. | -232 Million USD | 16.718% |
| MiMedx Group, Inc. | -33.9 Million USD | -469.939% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1995.194% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -8238.919% |
| NextCure, Inc. | -6.47 Million USD | -2883.094% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -282.596% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2928.923% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1688.512% |
| Vaxcyte, Inc. | -368.22 Million USD | 47.528% |
| PDS Biotechnology Corporation | -32.7 Million USD | -490.711% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1218.272% |
| Pharming Group N.V. | 109.8 Million USD | 275.964% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1010.686% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -10.264% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -943.286% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -943.286% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2621.338% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3197.184% |
| Acelyrin, Inc. | -216.9 Million USD | 10.921% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3343.954% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -11107.367% |
| Summit Therapeutics Inc. | 34.67 Million USD | 657.233% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2740.144% |
| Senti Biosciences, Inc. | 1.74 Million USD | 11204.31% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -4.663% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -149.467% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3087.314% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 193762.36% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 30866.72% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -65.076% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -14.85% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 274.272% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2443.641% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -49.647% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2902.411% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 20.279% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1003.468% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 38.992% |
| MEI Pharma, Inc. | -3.7 Million USD | -5114.98% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1644.361% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 219.459% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 795.193% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2620.744% |
| Precigen, Inc. | -481 Thousand USD | -40069.439% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1472.168% |
| AlloVir, Inc. | -62.69 Million USD | -208.197% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -247.422% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 413.325% |
| ImmuCell Corporation | 10.99 Million USD | 1858.008% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -25.345% |
| Onconetix, Inc. | 5.33 Million USD | 3724.07% |
| PureTech Health plc | -167.19 Million USD | -15.561% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -534.324% |
| Elevation Oncology, Inc. | -19.11 Million USD | -910.644% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3835.934% |
| Seer, Inc. | -4.24 Million USD | -4456.958% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -703.823% |
| Innoviva, Inc. | 255.56 Million USD | 175.604% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -245.867% |
| ESSA Pharma Inc. | -33.62 Million USD | -474.675% |
| GlycoMimetics, Inc. | -40.98 Million USD | -371.435% |
| GT Biopharma, Inc. | -1.02 Million USD | -18824.094% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -185.049% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 415.417% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -44.105% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1294.45% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -569.212% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -256377.819% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -526.061% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2257.759% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -6074.941% |
| Soligenix, Inc. | -4.95 Million USD | -3802.074% |
| Century Therapeutics, Inc. | 847 Thousand USD | 22911.688% |
| Kura Oncology, Inc. | -20.11 Million USD | -860.409% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -372.108% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2200.726% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 10706.331% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -5943.635% |
| Autolus Therapeutics plc | -186.59 Million USD | -3.546% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -291.885% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 29.942% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 663.835% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 217.55% |
| GRI Bio, Inc. | -1.79 Million USD | -10670.067% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2050.885% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -480.975% |
| IGM Biosciences, Inc. | -72.6 Million USD | -166.114% |
| INmune Bio, Inc. | -25.41 Million USD | -660.36% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 227.998% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -281.403% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1089.061% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -6597.399% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 608.26% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -369.139% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 705.975% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 151.122% |
| Verastem, Inc. | -37.27 Million USD | -418.308% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2029.56% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -272.556% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1176.611% |
| Histogen Inc. | -7.48 Million USD | -2480.673% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -794.232% |
| Surrozen, Inc. | -32.66 Million USD | -491.523% |
| Organovo Holdings, Inc. | -1.5 Million USD | -12721.168% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4496.54% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1119.055% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 7485.894% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4749.062% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2205.352% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -344.765% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1225.491% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 39.008% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -26658.857% |
| Apollomics, Inc. | -27.39 Million USD | -605.293% |
| Amarin Corporation plc | -191.04 Million USD | -1.139% |
| Mesoblast Limited | 55.96 Million USD | 445.255% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1224.842% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -663.937% |
| Synaptogenix, Inc. | -28.66 Million USD | -574.127% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -20542.628% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 496.485% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -22312.419% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2559.137% |
| Exelixis, Inc. | -73.05 Million USD | -164.497% |
| Better Therapeutics, Inc. | -860 Thousand USD | -22366.86% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -704.627% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 19.951% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 26349.684% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2497.627% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 15507.895% |
| Gritstone bio, Inc. | 39.49 Million USD | 589.276% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -129.742% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -7240.605% |
| Avid Bioservices, Inc. | 169.72 Million USD | 213.838% |
| Insmed Incorporated | 721.62 Million USD | 126.775% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2013.6% |
| MediWound Ltd. | -5.32 Million USD | -3530.496% |
| OmniAb, Inc. | 9.2 Million USD | 2199.478% |
| Alector, Inc. | -35.63 Million USD | -442.175% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 324.744% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3820.759% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1559.438% |
| Zai Lab Limited | -775 Million USD | 75.069% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 156.735% |
| Aura Biosciences, Inc. | -21.52 Million USD | -797.631% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -134.257% |
| Immunic, Inc. | -45.34 Million USD | -326.147% |
| Veracyte, Inc. | -203.82 Million USD | 5.205% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 130.271% |
| FibroGen, Inc. | 56.76 Million USD | 440.365% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2269.736% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -6734.432% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -9232.489% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 104.209% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -5683.149% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -16.42% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1181.71% |
| Galecto, Inc. | -21.21 Million USD | -810.704% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -712.34% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 112.311% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -689.535% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1579.108% |
| XBiotech Inc. | -200.02 Million USD | 3.404% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -129.742% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 4367.116% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -447.926% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -150.22% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3495.098% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -13.379% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -109.166% |
| Vaxxinity, Inc. | 10.13 Million USD | 2006.978% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 126.243% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1694.419% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -192.945% |
| NexImmune, Inc. | -3.13 Million USD | -6065.827% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -5496.099% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1178.6% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -612.97% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2052.561% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -154999.338% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -376.227% |
| Ainos, Inc. | 4.07 Million USD | 4838.068% |
| Pluri Inc. | 22.82 Million USD | 946.358% |
| Prothena Corporation plc | -608.34 Million USD | 68.239% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -62.699% |
| Celularity Inc. | 65.19 Million USD | 396.387% |
| Rallybio Corporation | -24.1 Million USD | -701.655% |
| Cue Biopharma, Inc. | -33.81 Million USD | -471.321% |
| MeiraGTx Holdings plc | -40.3 Million USD | -379.418% |
| Omeros Corporation | 331.17 Million USD | 158.342% |
| Humacyte, Inc. | -22.48 Million USD | -759.268% |
| Immunocore Holdings plc | -358.59 Million USD | 46.119% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -686.226% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -525.271% |
| Blueprint Medicines Corporation | 702.83 Million USD | 127.491% |
| CalciMedica, Inc. | -5.53 Million USD | -3393.942% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -2.654% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1791.668% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -382.591% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -481.045% |
| Pulmatrix, Inc. | -10.41 Million USD | -1754.805% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3132.642% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -406.568% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -73.439% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -222.326% |
| Cytokinetics, Incorporated | 642.37 Million USD | 130.078% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -3218.135% |
| Nutriband Inc. | -251.65 Thousand USD | -76677.121% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -466.297% |
| Vor Biopharma Inc. | 4.3 Million USD | 4593.372% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.799% |
| Evogene Ltd. | -19.63 Million USD | -884.084% |
| ProKidney Corp. | -56.23 Million USD | -243.579% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -296.974% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1991.708% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 114.166% |
| CorMedix Inc. | -43.05 Million USD | -348.789% |
| BioLineRx Ltd. | 7.33 Million USD | 2733.792% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -603.495% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 518.695% |
| Atai Life Sciences N.V. | -28.55 Million USD | -576.57% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 8762.295% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -746.84% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1189.456% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -157.366% |
| MediciNova, Inc. | -50.78 Million USD | -280.468% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -145.181% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -858824.205% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2894.379% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 3.306% |
| Biomea Fusion, Inc. | -166.57 Million USD | -15.996% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -7.956% |
| Mereo BioPharma Group plc | -51.46 Million USD | -275.401% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -103.719% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 34.227% |
| Absci Corporation | -72.59 Million USD | -166.144% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4331.603% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 17.583% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -105.088% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -101.905% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -394.497% |
| Allakos Inc. | -24.97 Million USD | -673.634% |
| Imunon, Inc. | -4.21 Million USD | -4485.235% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1210.643% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -42.699% |
| BioAtla, Inc. | -109.01 Million USD | -77.244% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 26349.684% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -20476.677% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1714.7% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -811.263% |
| XOMA Corporation | -29 Million USD | -566.259% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1066.757% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2043.024% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2493.838% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -55.023% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 7.181% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -136.265% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -108.289% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -22388.198% |
| Akari Therapeutics, Plc | -3.84 Million USD | -4925.098% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 12005.613% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 113.992% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -16162.041% |
| UroGen Pharma Ltd. | 4.39 Million USD | 4500.251% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 270.262% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 268595.873% |
| Orgenesis Inc. | 21.78 Million USD | 986.958% |
| Entera Bio Ltd. | -10.62 Million USD | -1717.81% |
| GH Research PLC | -78.07 Million USD | -147.467% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -766.901% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -624.765% |
| Xencor, Inc. | 29.64 Million USD | 751.785% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -9708.804% |
| Replimune Group, Inc. | 1.41 Million USD | 13783.782% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -78792.89% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -52.839% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -16162.041% |
| Portage Biotech Inc. | -4.98 Million USD | -3779.04% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -858824.205% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -192.21% |
| OncoCyte Corporation | -6.56 Million USD | -2844.004% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 21630.221% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -4141.223% |
| Purple Biotech Ltd. | -14.13 Million USD | -1266.636% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -713.331% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2852.101% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1057.519% |
| HilleVax, Inc. | -165.48 Million USD | -16.757% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -7512.884% |
| Tharimmune, Inc. | -10.93 Million USD | -1666.884% |
| Genprex, Inc. | -6.73 Million USD | -2767.7% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 47.611% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -118.421% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -13691.221% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -5725.087% |
| OKYO Pharma Limited | -826.84 Thousand USD | -23267.656% |
| Savara Inc. | 153 Thousand USD | 126384.314% |
| Curis, Inc. | -23.88 Million USD | -708.871% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3645.993% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -24798.455% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -3012.355% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 16405.063% |
| BeiGene, Ltd. | -2.25 Billion USD | 91.424% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1665.952% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 68.232% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -4.111% |
| Erasca, Inc. | -37.21 Million USD | -419.172% |
| bluebird bio, Inc. | 108.57 Million USD | 277.962% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -14902.411% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 151.014% |
| DBV Technologies S.A. | -126.98 Million USD | -52.155% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -14902.411% |
| Moderna, Inc. | -2.9 Billion USD | 93.353% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1766.451% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1677.834% |
| Molecular Templates, Inc. | 707 Thousand USD | 27428.854% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -515.903% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 155.745% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -135.45% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -110.634% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -498.708% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -462.064% |
| MacroGenics, Inc. | -66.98 Million USD | -188.445% |
| RenovoRx, Inc. | -1.17 Million USD | -16371.867% |
| Adicet Bio, Inc. | -138.78 Million USD | -39.217% |
| Prime Medicine, Inc. | -27.94 Million USD | -591.511% |
| Aditxt, Inc. | 18.12 Million USD | 1166.256% |
| Adagene Inc. | -87.62 Million USD | -120.496% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4538.539% |
| Quantum-Si incorporated | -118.55 Million USD | -62.972% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 636.634% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2485.097% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -298.308% |
| SciSparc Ltd. | -2.06 Million USD | -9256.659% |
| Vericel Corporation | 1.27 Million USD | 15230.384% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1511.239% |
| Minerva Neurosciences, Inc. | 41 Million USD | 571.207% |
| Generation Bio Co. | 31.44 Million USD | 714.395% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -10.179% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -524.826% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 265.717% |
| Invivyd, Inc. | -198.47 Million USD | 2.651% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -114.041% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -7958.387% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -172.941% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2730.989% |
| 2seventy bio, Inc. | 181.71 Million USD | 206.329% |
| ADMA Biologics, Inc. | 90.06 Million USD | 314.526% |
| Clene Inc. | 3.34 Million USD | 5884.88% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2027.285% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -798.215% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2894.379% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 43.853% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -643.144% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 208.752% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4622.274% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3962.755% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3609.253% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -48.28% |
| Evaxion Biotech A/S | 5.28 Million USD | 3754.638% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -71.643% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -47.186% |
| Trevena, Inc. | 2.25 Million USD | 8656.909% |
| Surrozen, Inc. | -32.66 Million USD | -491.523% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -275.102% |
| Cingulate Inc. | 3.08 Million USD | 6367.754% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -6478.652% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2788.396% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1979.542% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -143.58% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -46.985% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -83.069% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4800.654% |
| Kronos Bio, Inc. | -36.05 Million USD | -435.904% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2153.513% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 13350.903% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -256.117% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1440.244% |
| ImmunityBio, Inc. | 618.22 Million USD | 131.253% |
| Korro Bio, Inc. | -132.94 Million USD | -45.337% |
| Kineta, Inc. | -4.54 Million USD | -4154.9% |
| BioVie Inc. | -17.73 Million USD | -989.619% |
| Codexis, Inc. | -43.27 Million USD | -346.523% |
| Celularity Inc. | 65.19 Million USD | 396.387% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -5997.034% |
| Celcuity Inc. | 6.78 Million USD | 2948.305% |
| Virax Biolabs Group Limited | -3.36 Million USD | -5641.997% |
| Cibus, Inc. | -8.07 Million USD | -2291.867% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -4468.811% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 4327.899% |
| IN8bio, Inc. | -16.38 Million USD | -1078.931% |
| Kodiak Sciences Inc. | -103.87 Million USD | -86.007% |
| Annexon, Inc. | -193.75 Million USD | 0.279% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 536808.333% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1004.149% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -5400.0% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 118.327% |
| Eyenovia, Inc. | 1.25 Million USD | 15450.337% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 818.138% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5857.909% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -481.15% |
| Arcellx, Inc. | -296.95 Million USD | 34.935% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -890.541% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -228.178% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -832.19% |
| Moolec Science SA | 117.61 Thousand USD | 164376.119% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -403.177% |
| Geron Corporation | 14.76 Million USD | 1408.956% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -409.56% |
| Royalty Pharma plc | 5.65 Billion USD | 103.415% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -36.624% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2664.391% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3502.836% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -37.294% |
| Humacyte, Inc. | -22.48 Million USD | -759.268% |
| Structure Therapeutics Inc. | -124.33 Million USD | -55.394% |
| 89bio, Inc. | -289.05 Million USD | 33.156% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -665.45% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -10736.511% |
| Genelux Corporation | -6.89 Million USD | -2700.623% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -522.09% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 331.121% |
| Notable Labs, Ltd. | -9.77 Million USD | -1876.422% |
| Liquidia Corporation | -80.17 Million USD | -140.989% |
| Mustang Bio, Inc. | -3.73 Million USD | -5071.708% |
| Immunovant, Inc. | -635.22 Million USD | 69.583% |
| Quantum-Si incorporated | -118.55 Million USD | -62.972% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1000.063% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -4563.65% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2507.064% |
| Acasti Pharma Inc. | -23 Million USD | -739.883% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -5638.101% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1089.061% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -40.275% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -6100.018% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -769.085% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -940.525% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -14.141% |
| PepGen Inc. | -60.67 Million USD | -218.469% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -740.943% |
| United Therapeutics Corporation | -507.7 Million USD | 61.943% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -910.222% |
| Solid Biosciences Inc. | -47.75 Million USD | -304.639% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -22312.419% |
| Immuneering Corporation | -54.94 Million USD | -251.665% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4496.54% |
| Silo Pharma, Inc. | -3.52 Million USD | -5382.353% |
| Belite Bio, Inc | -87.27 Million USD | -121.397% |
| XOMA Corporation | -29 Million USD | -566.259% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -173.3% |
| Bionomics Limited | 227 Million USD | 185.113% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -66.161% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7527.912% |
| uniQure N.V. | -102.95 Million USD | -87.677% |
| Cassava Sciences, Inc. | -121.13 Million USD | -59.503% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4538.539% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 571.82% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1515.375% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -6144.425% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 182378.302% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5857.909% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2269.736% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2505.38% |
| Altimmune, Inc. | -134.48 Million USD | -43.668% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 197.551% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7527.912% |
| Compugen Ltd. | -12.9 Million USD | -1397.326% |
| Peak Bio, Inc. | 10.34 Million USD | 1968.588% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -68173.852% |
| Benitec Biopharma Inc. | -50.58 Million USD | -281.984% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -85.182% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1083.533% |
| Zura Bio Limited | -99.8 Million USD | -93.591% |
| PolyPid Ltd. | 6.17 Million USD | 3231.524% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 360.679% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1083.533% |
| Instil Bio, Inc. | 75.35 Million USD | 356.396% |
| argenx SE | -2.02 Billion USD | 90.477% |
| Immunome, Inc. | -97.02 Million USD | -99.131% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -758.924% |
| Verona Pharma plc | -220.44 Million USD | 12.351% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -169.315% |
| Shattuck Labs, Inc. | -121.42 Million USD | -59.124% |
| CervoMed Inc. | -7.79 Million USD | -2379.389% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -4.16% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -4318.363% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -46.664% |
| Moolec Science SA | 117.61 Thousand USD | 164376.119% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -8344.796% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1315.313% |
| AnaptysBio, Inc. | -18.15 Million USD | -964.487% |
| Design Therapeutics, Inc. | -18.15 Million USD | -964.545% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -174.527% |
| NeurAxis, Inc. | 145.7 Thousand USD | 132711.531% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1820.219% |
| Lumos Pharma, Inc. | -28.49 Million USD | -578.114% |
| Achilles Therapeutics plc | -126.92 Million USD | -52.229% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -169.315% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -29365.634% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -830.089% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 13350.903% |
| Nutriband Inc. | -251.65 Thousand USD | -76677.121% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1366.973% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2496.976% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 156.795% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 914.051% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 56.821% |
| Palisade Bio, Inc. | -12.06 Million USD | -1501.716% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -37.705% |
| Beam Therapeutics Inc. | -262.72 Million USD | 26.456% |
| Neurogene Inc. | -131.95 Million USD | -46.425% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 985.657% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3859.324% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 48.775% |
| Sesen Bio, Inc. | -112.55 Million USD | -71.666% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -93.486% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -8129.644% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -395.093% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -132.001% |
| Athira Pharma, Inc. | -88.99 Million USD | -117.098% |
| Vaccinex, Inc. | -1.28 Million USD | -14901.165% |
| HCW Biologics Inc. | 2.85 Million USD | 6863.63% |
| XOMA Corporation | -29 Million USD | -566.259% |
| Nektar Therapeutics | 210.24 Million USD | 191.902% |
| Arvinas, Inc. | -313.8 Million USD | 38.427% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 12005.613% |
| Merus N.V. | -192.88 Million USD | -0.172% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 422.106% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2684.88% |
| Rezolute, Inc. | -68.16 Million USD | -183.439% |
| Clene Inc. | 3.34 Million USD | 5884.88% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1365.193% |
| BeyondSpring Inc. | -13.75 Million USD | -1304.689% |
| Synlogic, Inc. | -6.68 Million USD | -2790.277% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 17138.36% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2185.216% |
| Peak Bio, Inc. | 10.34 Million USD | 1968.588% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -134.427% |
| Krystal Biotech, Inc. | -350.23 Million USD | 44.833% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 255.662% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -14.331% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -6019.93% |
| MannKind Corporation | 143.89 Million USD | 234.271% |
| Ikena Oncology, Inc. | -109.15 Million USD | -77.008% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2452.041% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -483.731% |
| Gossamer Bio, Inc. | 180.35 Million USD | 207.13% |
| CohBar, Inc. | -5.93 Million USD | -3157.861% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -549.506% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4331.603% |
| Legend Biotech Corporation | -949.39 Million USD | 79.649% |
| Mural Oncology plc | -255.84 Million USD | 24.479% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 699.767% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -4001.67% |
| Disc Medicine, Inc. | -358.28 Million USD | 46.072% |
| Champions Oncology, Inc. | 4.81 Million USD | 4115.274% |
| REGENXBIO Inc. | 54.76 Million USD | 452.788% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -71751.979% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -27.937% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2043.973% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -139.474% |
| Vaxart, Inc. | -8.24 Million USD | -2244.558% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -285.044% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -51.94% |
| Cellectis S.A. | -43.85 Million USD | -340.577% |
| Longeveron Inc. | -2.9 Million USD | -6544.257% |
| Repare Therapeutics Inc. | -107.85 Million USD | -79.138% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 119.952% |
| Inozyme Pharma, Inc. | 12 Million USD | 1709.588% |
| Revolution Medicines, Inc. | -608.2 Million USD | 68.232% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -15608.537% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 27.121% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -28.748% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1134.837% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -26010.135% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.98% |
| Denali Therapeutics Inc. | -74.86 Million USD | -158.085% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1511.239% |
| Veru Inc. | 4.77 Million USD | 4142.181% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1618.078% |
| Cingulate Inc. | 3.08 Million USD | 6367.754% |
| Passage Bio, Inc. | 4.58 Million USD | 4314.068% |
| Context Therapeutics Inc. | -14.44 Million USD | -1237.144% |
| Exicure, Inc. | 5.84 Million USD | 3403.385% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 16.131% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -388.287% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1331.375% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -228.48% |
| Nuvalent, Inc. | -335.38 Million USD | 42.39% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 11240.543% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -159.412% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2073.397% |
| OmniAb, Inc. | 9.2 Million USD | 2199.478% |
| Anew Medical, Inc. | 1.43 Million USD | 13588.288% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1279.452% |
| Lipocine Inc. | -4.75 Million USD | -3963.756% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -75.925% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1368.564% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -281.403% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 876.213% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2774.795% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -193.519% |
| Ocugen, Inc. | -32.52 Million USD | -494.124% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -125.784% |
| Q32 Bio Inc. | -37.94 Million USD | -409.157% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -30666.72% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1328.154% |
| Equillium, Inc. | -22.39 Million USD | -762.875% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -655.691% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -492.198% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -77835.986% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 244.145% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 6141.745% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 58927.917% |
| Dominari Holdings Inc. | 195 Thousand USD | 99184.615% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3568.47% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2066.816% |
| Bio-Techne Corporation | 267.74 Million USD | 172.163% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1092.023% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -63.611% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2199.357% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1427.271% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 21.175% |
| Nkarta, Inc. | 57.29 Million USD | 437.205% |
| BioCardia, Inc. | 212 Thousand USD | 91239.151% |
| Iterum Therapeutics plc | 13.43 Million USD | 1537.826% |